Fatal pulmonary embolism in hospitalized patients: a large autopsy-based matched case-control study

Carregando...
Imagem de Miniatura
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2013
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CLINICS, v.68, n.5, p.679-685, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE: Pulmonary embolism is an underdiagnosed major cause of death for hospitalized patients. The objective of this study was to identify the conditions associated with fatal pulmonary embolism in this population. METHODS: A total of 13,074 autopsy records were evaluated in a case-control study. Patients were matched by age, sex, and year of death, and factors potentially associated with fatal pulmonary embolism were analyzed using univariate and multivariate conditional logistic regression. RESULTS: Pulmonary embolism was considered fatal in 328 (2.5%) patients. In the multivariate analysis, conditions that were more common in patients who died of pulmonary embolism were atherosclerosis, congestive heart failure, and neurological surgery. Some conditions were negatively associated with fatal pulmonary embolism, including hemorrhagic stroke, aortic aneurism, cirrhosis, acquired immune deficiency syndrome, and pneumonia. In the control group, patients with hemorrhagic stroke and aortic aneurism had short hospital stays (8.5 and 8.8 days, respectively), and the hemorrhage itself was the main cause of death in most of them (90.6% and 68.4%, respectively), which may have prevented the development of pulmonary embolism. Cirrhotic patients in the control group also had short hospital stays (7 days), and 50% died from bleeding complications. CONCLUSIONS: In this large autopsy study, atherosclerosis, congestive heart failure, and neurological surgery were diagnoses associated with fatal pulmonary embolism.
Palavras-chave
Heart Failure, Neurosurgery, Pulmonary Embolism
Referências
  1. Ahonkhai AA, 2008, JAIDS-J ACQ IMM DEF, V48, P310, DOI 10.1097/QAI.0b013e318163bd70
  2. ALPERT JS, 1994, PROG CARDIOVASC DIS, V36, P417, DOI 10.1016/S0033-0620(94)80050-2
  3. Ayoub T, 2008, J ROY SOC MED, V101, P177, DOI 10.1258/jrsm.2008.070479
  4. Beemath A, 2006, AM J CARDIOL, V98, P793, DOI 10.1016/j.amjcard.2006.03.064
  5. Cohen AT, 2008, LANCET, V371, P1914
  6. Coradazzi AL, 2003, BRAZ J MED BIOL RES, V36, P385, DOI 10.1590/S0100-879X2003000300014
  7. Cortez-Escalante Juan Jose, 2006, Revista do Instituto de Medicina Tropical de Sao Paulo, V48, P105, DOI 10.1590/S0036-46652006000200010
  8. Deheinzelin D, 2006, J THROMB HAEMOST, V4, P1266, DOI 10.1111/j.1538-7836.2006.01981.x
  9. Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656
  10. Glynn RJ, 2009, NEW ENGL J MED, V360, P1851, DOI 10.1056/NEJMoa0900241
  11. Goldhaber SZ, 2004, LANCET, V363, P1295, DOI 10.1016/S0140-6736(04)16004-2
  12. GOLDHABER SZ, 1982, AM J MED, V73, P822, DOI 10.1016/0002-9343(82)90764-1
  13. GOLDMAN L, 1983, NEW ENGL J MED, V308, P1000, DOI 10.1056/NEJM198304283081704
  14. GOODMAN LR, 1995, AM J ROENTGENOL, V164, P1369
  15. Hoyert DL, 2007, VITAL HLTH STAT, V20, P1
  16. Khaldi A, 2011, J NEUROSURG, V114, P40, DOI 10.3171/2010.8.JNS10332
  17. Kotovicz F, 2008, CLINICS, V63, P581, DOI 10.1590/S1807-59322008000500003
  18. LINDBLAD B, 1991, BRIT MED J, V302, P709
  19. Michiels Jan Jacques, 2005, Semin Vasc Med, V5, P351, DOI 10.1055/s-2005-922480
  20. Michiels JJ, 2005, INT ANGIOL, V24, P27
  21. Morpurgo M, 1998, INT J CARDIOL, V65, pS79, DOI 10.1016/S0167-5273(98)00069-2
  22. Nicolaides AN, 2001, INT ANGIOL, V20, P1
  23. Pai M, 2011, THROMB RES, V128, P422, DOI 10.1016/j.thromres.2011.05.012
  24. Perkins GD, 2003, CRIT CARE, V7, pR129, DOI 10.1186/cc2359
  25. Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905
  26. Pineda LA, 2001, CHEST, V120, P791, DOI 10.1378/chest.120.3.791
  27. Prandoni P, 2007, J THROMB HAEMOST, V5, P270, DOI 10.1111/j.1538-7836.2007.02467.x
  28. Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157
  29. Rizkallah J, 2009, CHEST, V135, P786, DOI 10.1378/chest.08-1516
  30. Rocha Ana T, 2007, Vasc Health Risk Manag, V3, P533
  31. Rosenbaum GE, 2000, ARCH INTERN MED, V160, P374, DOI 10.1001/archinte.160.3.374
  32. SANDLER DA, 1989, J ROY SOC MED, V82, P203
  33. Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849
  34. Stein PD, 2006, AM J MED, V119, P60, DOI 10.1016/j.amjmed.2005.06.058
  35. Thodiyil PA, 2002, THROMB HAEMOSTASIS, V87, P1076